Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation: Specificity of action and consequences on vasoreactivity;Effets sur la proliferation myo-intimale d'un oligonucleotide antisens dirige contre le c-myb. Specificite d'action et consequences sur la vasoreactivite

Archives des Maladies du Coeur et des Vaisseaux

Volumn 89, Issue 7, 1996, Pages 889-896

  Castier, Y ^a   Chemla, E ^a   Chardigny, C ^b   Nierat, J ^a   Eudes, D ^a   Vasseur, M A ^a   Bruneval, P ^a   Carpentier, A ^a   Fabiani, J N ^a  

^a HÔPITAL BROUSSAIS   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ONCOPROTEIN; PROTEIN C MYB; TRANSACTIVATOR PROTEIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; MALE; MUSCLE HYPERTROPHY; NONHUMAN; ONCOGENE C MYB; RAT; ANIMAL; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENETICS; HYPERPLASIA; INTIMA; MOLECULAR GENETICS; PATHOLOGY; PROTO ONCOGENE; SENSITIVITY AND SPECIFICITY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; AORTA, ABDOMINAL; CELL DIVISION; HYPERPLASIA; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; PROTO-ONCOGENES; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATORS; TUNICA INTIMA; VASOCONSTRICTION;

EID: 0030184954     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ip J, Fuster V, Badimon L, Badimon J, Taubman M, Chesebro J. Syndromes of accelerated atherosclerosis : role of vascular injury and smooth muscle proliferation. J Am Coll Cardiol 1990 ; 15 : 1667-87.
2. Ross R. The pathogenesis of atherosclerosis : a perspective for the 1990s. Nature 1993 ; 362 : 801-9.
3. Bauters C, Hamon M, Belle EV, Dupuis B, Lablanche JM, Bertrand ME. Resténose après angioplastie coronaire : apport des modèles expérimentaux. Arch Mal Cœur 1993 ; 86 : 47-56.
4. Dobrin P, Litooy F, Endean E. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 1989 ; 105 : 393-400.
5. Bauters C. Apport de la biologie moléculaire à la compréhension et au traitement de la resténose après angioplastie. Réalités cardiologiques 1993 ; 49 : 12-8.
6. Reidy MA, Fingerle J, Lindner V. Factors controlling the development or arterial lesions after injury. Circulation 1992 ; 86 : 43-6.
7. Franklin S, Faxon D. Pharmacological prevention of restenosis after coronary angioplasty : review of randomized clinical trials. Coronary Artery Dis 1993 ; 4 : 232-42.
8. Edelman E, Simons M, Sirois M, Rosenberg R. c-myc in vasculoproliferative disease. Circ Res 1995 ; 76 : 176-82.
9. Brown K, Kindy M, Sonenshein G. Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cell. J Biol Chem 1992 ; 267 : 249-51.
10. Hélène C, Saison-behmoaras E. La stratégie antisens : nouvelles approches thérapeutiques. Médecine/Sciences 1994 ; 10 : 253-73.
11. Simons M, Edelmaner ER, Dekeyser JL, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimai arterial smooth muscle cell accumulation in vivo. Nature 1992 ; 359 : 67-70.
12. Simons M, Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 1992 ; 70 : 835-43.
13. Chemlo E, Julia P, Nierat J et al. Action des oligonucléotides antisens sur l'hyperplasie myo-intimale dans un modèle de traumatisme d'aortes abdominales de rat. Arch Mal Cœur 1995 ; 88 : 381-9.
14. Bennet MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 1994 ; 93 : 820-8.
15. Shi Y, Hutchinson H, Hall D, Zalewski A. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Circulation 1993 ; 88 : 1190-5.
16. Villa A, Guzman L, Poptic E et al. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ Res 1995 ; 76 : 505-13.
17. Burgess T, Fisher E, Ross S et al. The antiproliferative activity of c-myb and antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci USA 1995 ; 92 : 4051-5.
18. Stemerman M, Weinstein R, Rowe J, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle growth kinetics in vivo in aged rats. Proc Natl Acad Sci USA 1982 ; 79 : 3863-96.
19. Edelman ER, Nugent MA, Karnovski MJ. Perivascular and intravenous bFGF administration : vascular and organ deposition. Proc Natl Acad Sci USA 1993 ; 30 : 1513-7.
20. Villa AE, Guzman LA, Poptic E. Local delivery of antisense c-myb for prevention of neo-intimal proliferation after balloon arterial injury. Circulation 1993 ; 88 : 71-81.
21. Shi Y, Fard A, Galeo A et al. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. circulation 1994 ; 90 : 944-51.
22. Stein C, Krieg A. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev 1994 ; 4 : 67-9.
23. Laughlan G, Murchie A, Norman D et al. The high-resolution crystal of a parallel-stranded guanine tetraplex. Science 1994 ; 265 : 520-4.
24. Dignan R, Yeh T, Dyke C et al. Reactivity of gastroepiploic and internal mammary arteries. Relevance to coronary artery bypass grafting. J Thorac Cardiovasc Surg 1992 ; 103 : 116-22.
25. Furchgott R, Zawadzki J. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 ; 288 : 373-6.
26. Brown G, Nanney L, Griffen J et al. Enhancement of wound healing by topical treatment with epidermic growth factor. N Engl J Med 1989 ; 321 : 76-9.
27. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987 ; 235 : 442-7.
28. Castellot J, Addonizio M, Rosenberg R, Karnovsky M. Cultured endothelial cells produce a hepann-like inhibition of smooth muscle cell migration by heparin-like glycosaminoglycan. J Cell Physiol 1981 ; 90 : 372-9.